Position in ANNX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$6,021,435
+$2,045,596 QoQ
Shares Held
1,086,902
+37.2% QoQ
Ownership
0.545%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 98.30490697413381.ToString("F0")%
Shared 1.6950930258661776.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ANNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026NORTHERN TRUST CORP holds $6,613,834,361 across 418 Biotechnology names. ANNX ranks #130 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,564,264 | $1,145,046,441 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
941,941 | $727,781,290 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
858,120 | $283,926,160 | |
| 4 | INSM |
INSMED Inc
|
1,294,000 | $211,594,876 | |
| 5 | RPRX |
Royalty Pharma plc
|
3,808,735 | $182,705,014 | |
| 6 | INCY |
Incyte Corp
|
1,849,726 | $174,096,208 | |
| 7 | MRNA |
Moderna, Inc.
|
2,952,041 | $149,963,680 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,403,642 | $104,234,453 |
All Filings in ANNX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,021,435 | 1,086,902 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $3,975,839 | 792,000 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $2,402,508 | 787,708 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $1,783,737 | 743,224 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $1,980,032 | 1,025,925 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $5,282,615 | 1,029,750 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $4,677,184 | 790,065 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $2,720,944 | 555,295 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $3,983,407 | 555,566 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $1,667,427 | 367,275 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $852,518 | 361,237 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,334,783 | 379,200 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $310,728 | 80,709 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $417,916 | 80,835 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $500,400 | 80,971 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $207,473 | 55,033 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $744,188 | 272,597 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $3,380,195 | 294,186 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $5,339,841 | 286,934 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $6,615,867 | 293,908 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $7,164,900 | 257,360 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $4,455,864 | 178,021 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $5,187,044 | 171,586 | Shares | Defined | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||